Apr 11, 2002 Saint-Laurent,Quebec
ART Advanced Research
Technologies Inc. (ART) (TSE "ARA"), a leading developer of optical and
infrared imaging technologies for the detection of anomalies in the medical
sector and the electronics industry is pleased to announce the repeat sale of
its ISIS(R) 2020 model, a semi-automatic infrared inspection system to a world-
leading electronics contract manufacturer.
"This sale to one of the major electronics contract manufacturers is an
acknowledgement of the effectiveness and efficiency of ART's innovative
ISIS(R) systems based on infrared verification imaging technology" states
Serge Huot, President and CEO of ART. "This is the third sale to our repeat
contract manufacturer client and we are optimistic that as economic activity
continues to increase, so will our sales of ISIS(R) systems". The recognition
by key players in both the medical sector and electronics industry of the
promise which our innovative optical imaging technology holds will facilitate
the consolidation of our cash position.
ABOUT ISIS(R)
The ISIS(R) infrared (IR) verification system provides an innovative,
fast, and cost effective end-of-line screening, and off-line inspection and
failure analysis tool to help manufacturers achieve the next level of process
improvement in the electronics printed circuit board assembly (PCBA) industry.
ISIS(R) does this by exploiting infrared imaging technology to find problems
with powered PCBA's. Use of IR technology provides ISIS(R) with a broad fault
coverage capability so that quality problems can be quickly identified and
resolved. ISIS(R) is available both in a semi-automatic version, the 2020
model, designed for off-line IR verification, and in an automated version, the
7070 model, designed for in-line IR verification.
ABOUT ART
ART Advanced Research Technologies Inc. is a North American company that
is involved in the research, design, development, and marketing of optical and
infrared imaging technologies used in the detection of anomalies in the
medical sector and the electronics industry. ART is in the process of bringing
to market an optical imaging device to detect and diagnose breast cancer. The
device, known as SoftScan(R), represents an innovative imaging solution for
the detection of breast cancer without the adverse consequences associated
with traditional technology. SoftScan(R) uses the time domain technique in
optical imaging, which generates the most information possible about tissue.
ART is also currently commercializing its ISIS(R) products, which are based on
infrared verification imaging technology, and are used to detect defects in
printed circuit board assemblies. ART has been listed on the Toronto Stock
Exchange since June 29, 2000 (TSE: "ARA").
